Fundz

SCIRENT Appoints Prof. Dr. Wilhelm Haverkamp as Chief Medical Officer

PRIVATEApr 16, 2026

Position

Chief Medical Officer

Company

SCIRENT

Wilhelm Haverkamp
prof.haverkamp@scirent.com
GermanyBiotechnologyHealth CareMedicalMedical Device

Description

SCIRENT announced the immediate appointment of Prof. Dr. Wilhelm Haverkamp as Chief Medical Officer

Quick answer

SCIRENT Appoints Prof. Dr. Wilhelm Haverkamp as Chief Medical Officer (April 16, 2026). SCIRENT is based in Germany.

Who is the new Chief Medical Officer at SCIRENT?
SCIRENT named Wilhelm Haverkamp Chief Medical Officer, announced April 16, 2026.
What did SCIRENT announce on April 16, 2026?
SCIRENT announced the immediate appointment of Prof.
What does SCIRENT do?
SCIRENT was founded in 2012 with the vision to help clients develop innovative therapies and medical devices for patients with cardiovascular diseases.
Where is SCIRENT based?
SCIRENT is based in Germany.
Which similar companies made leadership changes around the same time?
Olympus (April 16, 2026), Lumexa Imaging (April 20, 2026), Retractable Technologies (April 10, 2026) and ImpediMed (April 8, 2026) also announced leadership changes within 45 days of SCIRENT.

Source: Fundz verified event record.

Other recent leadership changes in Medical and Medical Device

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at SCIRENT, and when

A new leader at SCIRENT brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day SCIRENT raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at SCIRENT, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at SCIRENT. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

SCIRENT

Location

Germany

About

SCIRENT was founded in 2012 with the vision to help clients develop innovative therapies and medical devices for patients with cardiovascular diseases. The company focuses on drug safety and clinical oversight.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment SCIRENT changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Wilhelm
Likely contact at this company
••••••••@••••••••

See Wilhelm's verified email →

Elvis
Senior decision-maker at this company
••••••••@••••••••

See Elvis's verified email →

Ixart
Likely contact at this company
••••••••@••••••••

See Ixart's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for SCIRENT's next move

Learn about Strategic plan

SCIRENT changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.